By BY PAM BELLUCK AND REBECCA ROBBINS from NYT Health The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients. https://ift.tt/3veBqOD
10 Haziran 2021 Perşembe
Kaydol:
Kayıt Yorumları (Atom)
Routine Childhood Vaccinations in the U.S. Slipped During the Pandemic
By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...
-
By BY EMILY ANTHES from NYT Health The F.D.A. authorized a breath-based test made by a small Texas company, which said it hoped that mobile...
-
By BY CARL ZIMMER from NYT Health https://ift.tt/2IHUMZY
-
https://ift.tt/2qR64Cz
Hiç yorum yok:
Yorum Gönder